Home
Search

Press Releases

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Featured Press Releases
BIO Elects Genentech’s Fritz Bittenbender as New…
Industry veteran takes the helm as Dr. Ted Love concludes two-year term marked by strategic growth and transition BOSTON (June 16, 2025) – Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender,…
Learn more
BIO International Convention Opens in Boston,…
The world’s largest biotech gathering unites 20,000+ leaders to accelerate breakthroughs that heal, protect, and nourish humanityBOSTON (June 16, 2025) The BIO International Convention, the world’s largest and most comprehensive event for…
Learn more
BIO Statement on HHS Dismissal of CDC Advisory…
WASHINGTON, D.C. - John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding today’s dismissal of the voting members of the CDC Advisory Committee on Immunization Practices: …
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Applauds FDA Action on AquAdvantage® Salmon
March 8, 2019
The Biotechnology Innovation Organization (BIO) released the following statement on the action taken today by the U.S. Food & Drug Administration (FDA) which will allow AquaBounty Technologies, an American company, to commercialize its…
BIO Applauds Multi-Agency Framework for Advancing the Bioeconomy
March 5, 2019
The Biotechnology Innovation Organization (BIO) today released the following statement in response to the release of The Bioeconomy Initiative: Implementation Framework, a multi-agency strategy aimed at accelerating innovative technologies that…
BIO Statement on Ambassador Lighthizer and Secretary Perdue Testimonies
February 27, 2019
BIO President and CEO Jim Greenwood released the following statement on U.S. Trade Representative Robert Lighthizer’s testimony at a House Ways and Means Committee hearing on the U.S.-China trade deal and U.S. Secretary of Agriculture Sonny…
BIO Announces Partnership with Taiwan BIO for 2019 Conference and Exhibition
February 20, 2019
Washington, DC (February 20, 2019) – The Biotechnology Innovation Organization (BIO) announced today it will join the Taiwan Bio-Industry Organization (Taiwan BIO) to host BIO Asia-Taiwan from July 24-28 in Taipei, Taiwan. The event…
BIO Statement on CMS Proposed Decision Memo for the CAR-T National Coverage Determination
February 15, 2019
BIO Executive Vice President for Health Policy Dan Durham issued the following statement regarding the CMS proposed decision memo for the CAR-T National Coverage Determination.
BIO Applauds Sens. Tillis, Sinema, Peters, and Perdue for Introducing the Fostering Innovation Act
February 13, 2019
The Biotechnology Innovation Organization (BIO) applauds Sens. Thom Tillis (R-NC), Kyrsten Sinema (D-AZ), Gary Peters (D-MI), and David Perdue (R-GA) for introducing the Fostering Innovation Act (S.452) to build on the success of the Jumpstart Our…
BIO Announces Brent Erickson to Step Down as Executive Vice President, Industrial and Environmental Section
February 11, 2019
The Biotechnology Innovation Organization (BIO) announced today that after 19 years leading the Industrial and Environmental Section, Executive Vice President Brent Erickson will step down from the organization in March 2019 to begin new business…
New Report Demonstrates High Costs and Low Benefits of Sarbanes-Oxley 404(b) Compliance for Emerging Biotechs
February 11, 2019
Washington, DC (February 11, 2019) – Today, to recognize National Inventors’ Day, the Biotechnology Innovation Organization (BIO) released a new report, “Science or Compliance: Will Section 404(b) Compliance Impede Innovation by Emerging Growth…
BIO Encouraged by Improved U.S. Ranking in Global Index of Patent System Strength
February 7, 2019
But New Legislative Proposals Endanger Progress
BIO Statement on Hatch-Waxman Integrity Act of 2019
February 6, 2019
BIO applauds the leadership of Senator Thom Tillis (R- NC) and Congressman Bill Flores (R-17 TX) for introducing the “Hatch-Waxman Integrity Act of 2019” to preserve the time-tested approach of the HWA while strengthening the ability of patent…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today